Molecular profiling of EGFR family in chronic obstructive pulmonary disease: Correlation with airway obstruction

European Journal of Clinical Investigation

Volumn 43, Issue 12, 2013, Pages 1299-1306

  Anagnostis, Aristotelis ^a,b   Neofytou, Eirini ^b   Soulitzis, Nikolaos ^b   Kampas, Dimitris ^b   Drositis, Ioannis ^a   Dermitzaki, Despina ^a   Tzanakis, Nikolaos ^a   Schiza, Sofia ^a   Siafakas, Nikolaos M ^a,b   Tzortzaki, Eleni G ^a,b  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^b UNIVERSITY OF CRETE   (Greece)

Author keywords

Chronic obstructive pulmonary disease; Degree of airway obstruction; Epidermal growth factor receptor; Forced expiratory volume in first second; Smoking

Indexed keywords

COMPLEMENTARY DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; EPIDERMAL GROWTH FACTOR RECEPTOR 4; MESSENGER RNA;

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CILIATED EPITHELIUM; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENVIRONMENTAL EXPOSURE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS EPITHELIUM; LUNG NODULE; LUNG PARENCHYMA; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; SMOKING;

CHRONIC OBSTRUCTIVE PULMONARY DISEASE; DEGREE OF AIRWAY OBSTRUCTION; EPIDERMAL GROWTH FACTOR RECEPTOR; FORCED EXPIRATORY VOLUME IN FIRST SECOND; SMOKING;

AIRWAY OBSTRUCTION; DNA, COMPLEMENTARY; FORCED EXPIRATORY VOLUME; HUMANS; LUNG; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA; SMOKING; VITAL CAPACITY;

EID: 84888034800     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12178     Document Type: Article

References (35)

1. From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2013. Available at: http://www.goldcold.org. Accessed on 26 August 2013.
2. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007;370:765-73.
3. Lin JL, Thomas PS. Current perspectives of oxidative stress and its measurement in chronic obstructive pulmonary disease. COPD 2010;7:291-306.
4. Tzortzaki EG, Dimakou K, Neofytou E, Tsikritsaki K, Samara K, Avgousti M et al. Oxidative DNA damage and somatic mutations: a link to the molecular pathogenesis of chronic inflammatory airway diseases. Chest 2012;141:1243-50.
5. Tzortzaki EG, Siafakas NM. A hypothesis for the initiation of COPD. Eur Respir J 2009;34:310-5.
6. Cosio MG, Saetta M, Agusti A. Immunologic aspects of chronic obstructive pulmonary disease. N Engl J Med 2009;360:2445-54.
7. Burgel PR, Nadel JA. Epidermal growth factor receptor-mediated innate immune responses and their roles in airway diseases. Eur Respir J 2008;32:1068-81.
8. Chan HW, Smith NJ, Hannan RD, Thomas WG. Tackling the EGFR in pathological tissue remodelling. Pulm Pharmacol Ther 2006;19:74-8.
9. Schlessinger J. Ligand-induced, receptor-mediated dimerization and activation of EGF receptor. Cell 2002;110:669-72.
10. Schlessinger J, Ullrich A. Growth factor signaling by receptor tyrosine kinases. Neuron 1992;9:383-91.
11. Yarden Y, Sliwkowski MX. Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2001;2:127-37.
12. de Boer WI, Hau CM, van Schadewijk A, Stolk J, van Krieken JH, Hiemstra PS. Expression of epidermal growth factors and their receptors in the bronchial epithelium of subjects with chronic obstructive pulmonary disease. Am J Clin Pathol 2006;125:184-92.
13. O'Donnell RA, Richter A, Ward J, Angco G, Mehta A, Rousseau K et al. Expression of ErbB receptors and mucins in the airways of long term current smokers. Thorax 2004;59:1032-40.
14. Polosa R, Prosperini G, Leir SH, Holgate ST, Lackie PM, Davies DE. Expression of c-erbB receptors and ligands in human bronchial mucosa. Am J Respir Cell Mol Biol 1999;20:914-23.
15. Martin TR, Frevert CW. Innate immunity in the lungs. Proc Am Thorac Soc 2005;2:403-11.
16. Zaas AK, Schwartz DA. Innate immunity and the lung: defense at the interface between host and environment. Trends Cardiovasc Med 2005;15:195-202.
17. Aida S, Tamai S, Sekiguchi S, Shimizu N. Distribution of epidermal growth factor and epidermal growth factor receptor in human lung: immunohistochemical and immunoelectron-microscopic studies. Respiration 1994;61:161-6.
18. Boxall C, Holgate ST, Davies DE. The contribution of transforming growth factor-beta and epidermal growth factor signalling to airway remodelling in chronic asthma. Eur Respir J 2006;27:208-29.
19. Hardie WD, Bejarano PA, Miller MA, Yankaskas JR, Ritter JH, Whitsett JA et al. Immunolocalization of transforming growth factor alpha and epidermal growth factor receptor in lungs of patients with cystic fibrosis. Pediatr Dev Pathol 1999;2:415-23.
20. Raaberg L, Nexo E, Buckley S, Luo W, Snead ML, Warburton D. Epidermal growth factor transcription, translation, and signal transduction by rat type II pneumocytes in culture. Am J Respir Cell Mol Biol 1992;6:44-9.
21. Vermeer PD, Einwalter LA, Moninger TO, Rokhlina T, Kern JA, Zabner J et al. Segregation of receptor and ligand regulates activation of epithelial growth factor receptor. Nature 2003;422:322-6.
22. Zahm JM, Debordeaux C, Raby B, Klossek JM, Bonnet N, Puchelle E. Motogenic effect of recombinant HGF on airway epithelial cells during the in vitro wound repair of the respiratory epithelium. J Cell Physiol 2000;185:447-53.
23. Barsky SH, Roth MD, Kleerup EC, Simmons M, Tashkin DP. Histopathologic and molecular alterations in bronchial epithelium in habitual smokers of marijuana, cocaine, and/or tobacco. J Natl Cancer Inst 1998;90:1198-205.
24. Takeyama K, Dabbagh K, Jeong Shim J, Dao-Pick T, Ueki IF, Nadel JA. Oxidative stress causes mucin synthesis via transactivation of epidermal growth factor receptor: role of neutrophils. J Immunol 2000;164:1546-52.
25. Takeyama K, Jung B, Shim JJ, Burgel PR, Dao-Pick T, Ueki IF et al. Activation of epidermal growth factor receptors is responsible for mucin synthesis induced by cigarette smoke. Am J Physiol Lung Cell Mol Physiol 2001;280:L165-72.
26. Marinas AE, Ciurea P, Margaritescu C, Cotoi OS. Expression of epidermal growth factor (EGF) and its receptors (EGFR1 and EGFR2) in chronic bronchitis. Rom J Morphol Embryol 2012;53:957-66.
27. Amishima M, Munakata M, Nasuhara Y, Sato A, Takahashi T, Homma Y et al. Expression of epidermal growth factor and epidermal growth factor receptor immunoreactivity in the asthmatic human airway. Am J Respir Crit Care Med 1998;157:1907-12.
28. Polosa R, Puddicombe SM, Krishna MT, Tuck AB, Howarth PH, Holgate ST et al. Expression of c-erbB receptors and ligands in the bronchial epithelium of asthmatic subjects. J Allergy Clin Immunol 2002;109:75-81.
29. Selvaggi G, Scagliotti GV, Torri V, Novello S, Leonardo E, Cappia S et al. HER-2/neu overexpression in patients with radically resected nonsmall cell lung carcinoma. Impact on long-term survival. Cancer 2002;94:2669-74.
30. Kettle R, Simmons J, Schindler F, Jones P, Dicker T, Dubois G et al. Regulation of neuregulin 1beta1-induced MUC5AC and MUC5B expression in human airway epithelium. Am J Respir Cell Mol Biol 2010;42:472-81.
31. Yu H, Li Q, Kolosov VP, Perelman JM, Zhou X. Regulation of cigarette smoke-induced mucin expression by neuregulin1beta/ErbB3 signalling in human airway epithelial cells. Basic Clin Pharmacol Toxicol 2011;109:63-72.
32. Olayioye MA, Neve RM, Lane HA, Hynes NE. The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J 2000;19:3159-67.
33. Graus-Porta D, Beerli RR, Daly JM, Hynes NE. ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling. EMBO J 1997;16:1647-55.
34. Huang Z, Wang Y, Nayak PS, Dammann CE, Sanchez-Esteban J. Stretch-induced fetal type II cell differentiation is mediated via ErbB1 - ErbB4 interactions. J Biol Chem 2012;287:18091-102.
35. Vlachaki EM, Koutsopoulos AV, Tzanakis N, Neofytou E, Siganaki M, Drositis I et al. Altered surfactant protein-A expression in type II pneumocytes in COPD. Chest 2010;137:37-45.